Author

Bradley J. Van Sickle

Observed names: B.J Van Sickle, B.J. Van Sickle, Bradley J Van Sickle, Van Sickle Bj

Observed institutions: University of Toledo Medical Center, Monroe Carell Jr. Children's Hospital, Vanderbilt University, University of Toledo

OpenAlex ID: A5076813708

Enzyme-Replacement Therapy in Life-Threatening Hypophosphatasia

2012 · Michael P. Whyte, Cheryl R. Greenberg, et al. · New England Journal of Medicine · 564

Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus

2009 · Bradley J. Van Sickle, Jill Simmons, et al. · Cytokine · 48

Transient Plasticity of Hippocampal CA1 Neuron Glutamate Receptors Contributes to Benzodiazepine Withdrawal-Anxiety

2004 · Bradley J Van Sickle, Kun Xiang, et al. · Neuropsychopharmacology · 41

Chronic benzodiazepine administration alters hippocampal CA1 neuron excitability: NMDA receptor function and expression11Portions of this manuscript have been published in abstract form: Society for Neuroscience Abstracts 25:391.5, 1999 and 27:262.3, 2001.

2002 · B.J Van Sickle, A.S Cox, et al. · Neuropharmacology · 33

Selective enhancement of AMPA receptor-mediated function in hippocampal CA1 neurons from chronic benzodiazepine-treated rats

2002 · Bradley J Van Sickle, Elizabeth I Tietz · Neuropharmacology · 29

Calcium/Calmodulin-Dependent Protein Kinase II Mediates Hippocampal Glutamatergic Plasticity During Benzodiazepine Withdrawal

2010 · Guofu Shen, Bradley J Van Sickle, et al. · Neuropsychopharmacology · 25

ENB-0040, a bone-targeted human recombinant tissue nonspecific alkaline phosphatase (TNSALP) fusion protein, in the treatment of infants and adults with hypophosphatasia

2009 · M.P. Whyte, H. Landy, et al. · Bone · 1

Works count: 8

Citation count: 741

H-index: 6

I10-index: 6